|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,900.00 GBX | +0.62% |
|
-2.75% | -5.70% |
| 02-06 | FTSE 100 rises as heavyweight banks offset RELX drop; logs weekly gain | RE |
| 01-21 | Next Buys Russell & Bromley for GBP3 Million | MT |
| Fiscal Period: January | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.89 | 14.24 | 14.81 | 13.91 | 14.25 | |||||
Return on Total Capital | 7.24 | 17.71 | 19 | 18.19 | 19 | |||||
Return On Equity % | 52.01 | 81.09 | 65.35 | 57.1 | 43.81 | |||||
Return on Common Equity | 52.01 | 81.09 | 65.58 | 60.04 | 46.76 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.07 | 42.9 | 43.83 | 44.74 | 43.5 | |||||
SG&A Margin | 23.61 | 23.22 | 24.47 | 26.44 | 25.32 | |||||
EBITDA Margin % | 13.23 | 21.32 | 20.75 | 19.66 | 20.17 | |||||
EBITA Margin % | 9.91 | 19.08 | 18.76 | 17.81 | 18.29 | |||||
EBIT Margin % | 9.91 | 19.06 | 18.74 | 17.64 | 17.88 | |||||
Income From Continuing Operations Margin % | 8.11 | 14.65 | 14.12 | 14.58 | 12.15 | |||||
Net Income Margin % | 8.11 | 14.65 | 14.14 | 14.61 | 12.03 | |||||
Net Avail. For Common Margin % | 8.11 | 14.65 | 14.14 | 14.61 | 12.03 | |||||
Normalized Net Income Margin | 4.37 | 10.9 | 10.81 | 10.22 | 10.22 | |||||
Levered Free Cash Flow Margin | 10.17 | 8.25 | 8.28 | 12.67 | 11.39 | |||||
Unlevered Free Cash Flow Margin | 11.98 | 9.42 | 9.24 | 13.66 | 12.37 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.95 | 1.2 | 1.26 | 1.26 | 1.28 | |||||
Fixed Assets Turnover | 2.69 | 3.8 | 3.95 | 4.02 | 4.3 | |||||
Receivables Turnover (Average Receivables) | 2.85 | 3.93 | 4.05 | 4.17 | 4.53 | |||||
Inventory Turnover (Average Inventory) | 4.31 | 4.52 | 4.37 | 4.24 | 4.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.91 | 1.99 | 2.04 | 1.96 | 1.69 | |||||
Quick Ratio | 1.41 | 1.37 | 1.35 | 1.27 | 1.05 | |||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.8 | 0.73 | 0.9 | 0.72 | |||||
Days Sales Outstanding (Average Receivables) | 130 | 92.68 | 89.82 | 87.19 | 80.39 | |||||
Days Outstanding Inventory (Average Inventory) | 86.04 | 80.61 | 83.36 | 85.84 | 86.05 | |||||
Average Days Payable Outstanding | 31.03 | 29.78 | 32.2 | 30.54 | 33.45 | |||||
Cash Conversion Cycle (Average Days) | 185.01 | 143.5 | 140.98 | 142.49 | 132.99 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 370.27 | 208.54 | 165.29 | 117.65 | 106.98 | |||||
Total Debt / Total Capital | 78.74 | 67.59 | 62.31 | 54.05 | 51.69 | |||||
LT Debt/Equity | 280.34 | 169.37 | 143.96 | 103.83 | 79.54 | |||||
Long-Term Debt / Total Capital | 59.61 | 54.89 | 54.27 | 47.7 | 38.43 | |||||
Total Liabilities / Total Assets | 82.41 | 74.63 | 70.75 | 65.31 | 64 | |||||
EBIT / Interest Expense | 3.41 | 10.2 | 12.11 | 11.13 | 11.35 | |||||
EBITDA / Interest Expense | 5.89 | 12.72 | 14.79 | 13.76 | 14.3 | |||||
(EBITDA - Capex) / Interest Expense | 4.48 | 9.9 | 12.16 | 12.18 | 12.96 | |||||
Total Debt / EBITDA | 4.04 | 1.91 | 1.67 | 1.61 | 1.36 | |||||
Net Debt / EBITDA | 3.03 | 1.52 | 1.58 | 1.45 | 1.22 | |||||
Total Debt / (EBITDA - Capex) | 5.31 | 2.46 | 2.03 | 1.82 | 1.5 | |||||
Net Debt / (EBITDA - Capex) | 3.98 | 1.95 | 1.92 | 1.64 | 1.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -17.15 | 30.88 | 8.82 | 9.08 | 11.42 | |||||
Gross Profit, 1 Yr. Growth % | -26.31 | 60.12 | 11.18 | 11.34 | 8.35 | |||||
EBITDA, 1 Yr. Growth % | -52.04 | 110.89 | 5.94 | 3.34 | 15.01 | |||||
EBITA, 1 Yr. Growth % | -59.07 | 151.9 | 7 | 3.6 | 14.46 | |||||
EBIT, 1 Yr. Growth % | -59.08 | 151.83 | 6.98 | 2.67 | 12.92 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -53.02 | 136.31 | 4.9 | 12.64 | -7.16 | |||||
Net Income, 1 Yr. Growth % | -53.02 | 136.31 | 5.05 | 12.73 | -8.25 | |||||
Normalized Net Income, 1 Yr. Growth % | -66.96 | 226.28 | 7.93 | 1.19 | 11.48 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -52.67 | 136.14 | 8.87 | 14.97 | -7.68 | |||||
Accounts Receivable, 1 Yr. Growth % | -17.34 | 13.98 | 9.28 | 2.77 | 2.69 | |||||
Inventory, 1 Yr. Growth % | 1.76 | 17.9 | 4.61 | 16.13 | 12.51 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -16.51 | 3.79 | 5.37 | 8.82 | 0.11 | |||||
Total Assets, 1 Yr. Growth % | 2.31 | 5.96 | 0.05 | 18.59 | 3.14 | |||||
Tangible Book Value, 1 Yr. Growth % | 51.12 | 55.01 | 9.96 | -26.26 | 19.37 | |||||
Common Equity, 1 Yr. Growth % | 49.69 | 52.82 | 14.9 | 30.28 | 8.23 | |||||
Cash From Operations, 1 Yr. Growth % | -11.04 | 17.77 | -17.77 | 40.25 | 1.21 | |||||
Capital Expenditures, 1 Yr. Growth % | 6.01 | 68.46 | -15.8 | -33.2 | -5.62 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -37.2 | 6.21 | 9.16 | 66.88 | 1.13 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -33.62 | 2.86 | 6.79 | 61.28 | 1.84 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 62.2 | 0.49 | 12.56 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -7.91 | 4.13 | 19.34 | 8.95 | 10.24 | |||||
Gross Profit, 2 Yr. CAGR % | -12.13 | 8.62 | 33.42 | 11.26 | 9.83 | |||||
EBITDA, 2 Yr. CAGR % | -30.21 | 0.57 | 49.47 | 4.62 | 8.69 | |||||
EBITA, 2 Yr. CAGR % | -35.42 | 1.54 | 64.18 | 5.27 | 8.9 | |||||
EBIT, 2 Yr. CAGR % | -35.42 | 1.51 | 64.14 | 4.81 | 7.68 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -30.82 | 5.37 | 57.45 | 8.7 | 2.26 | |||||
Net Income, 2 Yr. CAGR % | -30.82 | 5.37 | 57.56 | 8.82 | 1.7 | |||||
Normalized Net Income, 2 Yr. CAGR % | -41.94 | 3.83 | 87.66 | 5.48 | 6.21 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -28.93 | 5.72 | 60.34 | 11.88 | 3.02 | |||||
Accounts Receivable, 2 Yr. CAGR % | -8 | -2.94 | 11.61 | 5.98 | 2.73 | |||||
Inventory, 2 Yr. CAGR % | 3.34 | 9.53 | 11.06 | 10.22 | 14.3 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -11.01 | -6.91 | 4.58 | 7.08 | 4.38 | |||||
Total Assets, 2 Yr. CAGR % | 0.21 | 4.11 | 2.96 | 8.93 | 10.59 | |||||
Tangible Book Value, 2 Yr. CAGR % | 36.21 | 53.05 | 30.56 | -9.95 | -6.18 | |||||
Common Equity, 2 Yr. CAGR % | 34.34 | 51.25 | 32.51 | 22.35 | 18.74 | |||||
Cash From Operations, 2 Yr. CAGR % | -2.57 | 2.36 | -1.59 | 7.39 | 19.14 | |||||
Capital Expenditures, 2 Yr. CAGR % | 8.34 | 33.64 | 19.1 | -25.01 | -20.6 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -13.85 | -18.33 | 7.68 | 35 | 29.3 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.37 | -17.37 | 4.81 | 31.2 | 27.6 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 48.62 | - | 27.67 | 6.35 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.76 | 3.54 | 5.67 | 15.82 | 9.77 | |||||
Gross Profit, 3 Yr. CAGR % | -4.48 | 7.33 | 9.47 | 25.61 | 10.28 | |||||
EBITDA, 3 Yr. CAGR % | -18.97 | 0.9 | 2.33 | 32.16 | 7.76 | |||||
EBITA, 3 Yr. CAGR % | -22.77 | 1.66 | 3.33 | 40.8 | 8.25 | |||||
EBIT, 3 Yr. CAGR % | -22.76 | 1.65 | 3.31 | 40.38 | 7.44 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -21.46 | 4.18 | 5.21 | 40.81 | 3.13 | |||||
Net Income, 3 Yr. CAGR % | -21.46 | 4.18 | 5.26 | 40.92 | 2.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | -30.16 | 3.23 | 5.18 | 53.69 | 7.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -18.88 | 6.05 | 6.76 | 43.51 | 4.94 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.92 | -1.19 | 0.98 | 8.58 | 4.87 | |||||
Inventory, 3 Yr. CAGR % | 4.78 | 7.98 | 7.87 | 12.72 | 10.98 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 28.82 | -6.32 | -2.99 | 5.97 | 4.71 | |||||
Total Assets, 3 Yr. CAGR % | 13.63 | 2.09 | 2.74 | 7.93 | 6.96 | |||||
Tangible Book Value, 3 Yr. CAGR % | 10.94 | 42.21 | 37.08 | 7.92 | -1.08 | |||||
Common Equity, 3 Yr. CAGR % | 11.05 | 40.24 | 38.01 | 31.76 | 17.45 | |||||
Cash From Operations, 3 Yr. CAGR % | 10.27 | 3.79 | -4.85 | 10.75 | 5.29 | |||||
Capital Expenditures, 3 Yr. CAGR % | 8.63 | 25.51 | 14.56 | -1.78 | -19.03 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -1.82 | -7.62 | -10.04 | 24.63 | 22.23 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.8 | -7.56 | -9.99 | 20.98 | 20.22 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -8.36 | 53.01 | - | 22.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -3.29 | 2.46 | 4.24 | 5.67 | 7.48 | |||||
Gross Profit, 5 Yr. CAGR % | -3.13 | 7.43 | 9.18 | 8.88 | 9.61 | |||||
EBITDA, 5 Yr. CAGR % | -13.84 | 0.93 | 3.51 | 2.37 | 4.82 | |||||
EBITA, 5 Yr. CAGR % | -16.68 | 1.31 | 4.42 | 3.09 | 5.52 | |||||
EBIT, 5 Yr. CAGR % | -16.67 | 1.3 | 4.42 | 2.9 | 5.03 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -15.53 | 1.29 | 3.73 | 5.97 | 4.02 | |||||
Net Income, 5 Yr. CAGR % | -15.53 | 1.29 | 3.76 | 6.02 | 3.82 | |||||
Normalized Net Income, 5 Yr. CAGR % | -21.62 | 0.42 | 3.7 | 4.12 | 5.98 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -12.91 | 3.65 | 6.54 | 8.35 | 5.25 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.77 | 2.98 | 2.65 | 1.62 | 1.68 | |||||
Inventory, 5 Yr. CAGR % | 1.99 | 7.01 | 7.25 | 8.87 | 10.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.37 | 16.47 | 18.52 | -1.18 | -0.1 | |||||
Total Assets, 5 Yr. CAGR % | 10.03 | 10.61 | 9.23 | 4.77 | 5.81 | |||||
Tangible Book Value, 5 Yr. CAGR % | 17.5 | 14.78 | 18.41 | 18.45 | 17.79 | |||||
Common Equity, 5 Yr. CAGR % | 16.21 | 14.62 | 19.18 | 32.79 | 29.95 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.28 | 6.79 | 5.36 | 5.22 | 4.11 | |||||
Capital Expenditures, 5 Yr. CAGR % | -0.4 | 9.18 | 12.7 | 2.15 | -1.06 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.09 | 5.92 | 1.88 | 7.52 | 4.02 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.83 | 7.05 | 2.99 | 6.34 | 3.48 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | -4.27 | 5.45 | 4.64 | 32.29 |
- Stock Market
- Equities
- NXT Stock
- Financials Next plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















